**IMPORTANT**
The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Alzheimer's Association
a/k/a: ADRDA
Address:
225 North Michigan Avenue
Suite 1700
Chicago, IL 60601-7633
USA
Phone: 312-335-8700
Fax: 312-335-1110
800 Number: 800-272-3900
TDD: --
Email Address: info@alz.org
The Alzheimer's Association is a national, not-for-profit voluntary organization dedicated to promoting and supporting research into the causes, cure, and prevention of Alzheimer's disease and providing education and support services to people with Alzheimer’s Disease, their families, and caregivers. Established in 1980, the association works through a network of more than 220 local chapters, more than 2,000 support groups, and 35,000 volunteers nationwide. The goals of the Alzheimer's Association include education, chapter formation, advocacy for improved public policy and needed legislation, and patient and family services to aid present and future patients and caregivers. Activities of the association include the promotion of fund-raising for research through its Medical and Scientific Advisory Board; publication of the quarterly "Alzheimer's Association Newsletter"; and promotion of public awareness by publicizing such national annual events as Memory Walk and the national education conference. In addition, the association operates a 24-hour telephone hotline to assist people with Alzheimer's disease and their families.
Chapters: 81
Website: http://www.alz.org
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
Read about events on Capitol Hill, funding for rare-disease research, and other topics of interest from NORD's office in Washington, DC.